See today's BioWorld Science
To read the full story, subscribe or sign in.
Respiratory

Hpvac-13 demonstrates protection against allergic asthma in animal model

Oct. 18, 2022
Hpvac SA has announced new data on its lead compound Hpvac-13 for the treatment and prevention of asthmatic attacks in an animal disease model of allergic asthma.
BioWorld Science Respiratory